Berg D - Search Results

1

Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency.

Heinzel S, Metzger FG, Ehlis AC, Korell R, Alboji A, Haeussinger FB, Wurster I, Brockmann K, Suenkel U, Eschweiler GW, Maetzler W, Berg D, Fallgatter AJ. Heinzel S, et al. Among authors: berg d. PLoS One. 2015 Sep 22;10(9):e0138863. doi: 10.1371/journal.pone.0138863. eCollection 2015. PLoS One. 2015. PMID: 26394050 Free PMC article.

2

Cognitive response control in writer's cramp.

Berg D, Herrmann MJ, Müller TJ, Strik WK, Aranda D, Koenig T, Naumann M, Fallgatter AJ. Berg D, et al. Eur J Neurol. 2001 Nov;8(6):587-94. doi: 10.1046/j.1468-1331.2001.00298.x. Eur J Neurol. 2001. PMID: 11784343

3

Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model.

Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C. Maetzler W, et al. Among authors: berg d. Neurobiol Dis. 2007 Mar;25(3):473-82. doi: 10.1016/j.nbd.2006.10.020. Epub 2006 Dec 26. Neurobiol Dis. 2007. PMID: 17188882

4

Treatment of dementia in parkinsonian syndromes with cholinesterase inhibitors.

Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D. Liepelt I, et al. Among authors: berg d. Dement Geriatr Cogn Disord. 2007;23(6):351-67. doi: 10.1159/000101337. Epub 2007 Mar 26. Dement Geriatr Cogn Disord. 2007. PMID: 17389795 Free article. Review.

5

[Treatment for dementia in parkinsonian syndromes. Efficacy of cholinesterase inhibitors].

Liepelt I, Maetzler W, Blaicher HP, Gasser T, Berg D. Liepelt I, et al. Among authors: berg d. Nervenarzt. 2008 Jan;79(1):36-9, 42-6. doi: 10.1007/s00115-007-2312-2. Nervenarzt. 2008. PMID: 17687535 Review. German.

6

[11C]PIB binding in Parkinson's disease dementia.

Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K, Eschweiler GW, Mittelbronn M, Gaenslen A, Uebele M, Reischl G, Gasser T, Machulla HJ, Bares R, Berg D. Maetzler W, et al. Among authors: berg d. Neuroimage. 2008 Feb 1;39(3):1027-33. doi: 10.1016/j.neuroimage.2007.09.072. Epub 2007 Oct 22. Neuroimage. 2008. PMID: 18035558

7

Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.

Maetzler W, Liepelt I, Reimold M, Reischl G, Solbach C, Becker C, Schulte C, Leyhe T, Keller S, Melms A, Gasser T, Berg D. Maetzler W, et al. Among authors: berg d. Neurobiol Dis. 2009 Apr;34(1):107-12. doi: 10.1016/j.nbd.2008.12.008. Epub 2008 Dec 31. Neurobiol Dis. 2009. PMID: 19162186

8

A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease.

Maetzler W, Michelis J, Tomiuk J, Melms A, Becker C, Gasser T, Schulte C, Berg D. Maetzler W, et al. Among authors: berg d. J Neural Transm (Vienna). 2009 May;116(5):599-605. doi: 10.1007/s00702-009-0209-x. Epub 2009 Apr 2. J Neural Transm (Vienna). 2009. PMID: 19340392

9

No differences of butyrylcholinesterase protein activity and allele frequency in Lewy body diseases.

Maetzler W, Keller S, Michelis J, Koehler N, Stransky E, Becker C, Schulte C, Melms A, Gasser T, Berg D. Maetzler W, et al. Among authors: berg d. Neurobiol Dis. 2009 Aug;35(2):296-301. doi: 10.1016/j.nbd.2009.05.014. Epub 2009 May 27. Neurobiol Dis. 2009. PMID: 19481150

10

Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.

Liepelt I, Reimold M, Maetzler W, Godau J, Reischl G, Gaenslen A, Herbst H, Berg D. Liepelt I, et al. Among authors: berg d. Mov Disord. 2009 Jul 30;24(10):1504-11. doi: 10.1002/mds.22662. Mov Disord. 2009. PMID: 19489069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,415 results

Search Page

Filters